Published in Toxicol Appl Pharmacol on January 01, 2003
Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect (2005) 17.71
Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine (2008) 4.59
Nanoparticles - known and unknown health risks. J Nanobiotechnology (2004) 2.73
The nanosilica hazard: another variable entity. Part Fibre Toxicol (2010) 2.38
The impracticality of biomedical rejuvenation therapies: translational and pharmacological barriers. Rejuvenation Res (2014) 2.02
Cardiovascular effects of ambient particulate air pollution exposure. Circulation (2010) 1.67
Nanoparticles: health effects--pros and cons. Environ Health Perspect (2006) 1.63
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug Deliv Rev (2012) 1.18
Direct and indirect effects of particulate matter on the cardiovascular system. Toxicol Lett (2011) 1.11
Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells. Inhal Toxicol (2012) 1.02
Effects of airway exposure to nanoparticles on lung inflammation induced by bacterial endotoxin in mice. Environ Health Perspect (2006) 0.99
Matrix metalloproteinase-2 and -9 are induced differently by metal nanoparticles in human monocytes: The role of oxidative stress and protein tyrosine kinase activation. Toxicol Appl Pharmacol (2008) 0.98
Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation. Int J Nanomedicine (2014) 0.88
Xenobiotic particle exposure and microvascular endpoints: a call to arms. Microcirculation (2012) 0.88
Combination effects of cigarette smoke extract and ambient ultrafine particles on endothelial cells. Toxicol In Vitro (2011) 0.87
Nanotechnology: toxicologic pathology. Toxicol Pathol (2013) 0.87
Genotoxic responses to titanium dioxide nanoparticles and fullerene in gpt delta transgenic MEF cells. Part Fibre Toxicol (2009) 0.84
High-throughput, quantitative assessment of the effects of low-dose silica nanoparticles on lung cells: grasping complex toxicity with a great depth of field. BMC Genomics (2015) 0.82
Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation. Int J Nanomedicine (2014) 0.81
Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles. AAPS J (2014) 0.80
Impact of experimental type 1 diabetes mellitus on systemic and coagulation vulnerability in mice acutely exposed to diesel exhaust particles. Part Fibre Toxicol (2013) 0.80
Platelet activation independent of pulmonary inflammation contributes to diesel exhaust particulate-induced promotion of arterial thrombosis. Part Fibre Toxicol (2016) 0.80
Pulmonary and hemostatic toxicity of multi-walled carbon nanotubes and zinc oxide nanoparticles after pulmonary exposure in Bmal1 knockout mice. Part Fibre Toxicol (2014) 0.79
Assessing particle and fiber toxicology in the respiratory system: the stereology toolbox. Part Fibre Toxicol (2015) 0.78
Polymeric nanoparticles in development for treatment of pulmonary infectious diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78
Functionalized polystyrene nanoparticles as a platform for studying bio-nano interactions. Beilstein J Nanotechnol (2014) 0.78
Early pulmonary events of nose-only water pipe (shisha) smoking exposure in mice. Physiol Rep (2015) 0.78
New approach to investigate the cytotoxicity of nanomaterials using single cell mechanics. J Phys Chem B (2014) 0.76
Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation. Curr Med Chem (2016) 0.75
A co-culture system with an organotypic lung slice and an immortal alveolar macrophage cell line to quantify silica-induced inflammation. PLoS One (2015) 0.75
Nanosilica and Polyacrylate/Nanosilica: A Comparative Study of Acute Toxicity. Biomed Res Int (2016) 0.75
Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med (2002) 5.10
Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet (2011) 3.81
The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis (2009) 2.34
Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol (2009) 2.26
A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood (2009) 2.25
Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation (2003) 2.12
Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med (2002) 2.06
Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification. J Bone Miner Res (2007) 1.92
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood (2007) 1.86
Impact of a stepwise introduction of smoke-free legislation on the rate of preterm births: analysis of routinely collected birth data. BMJ (2013) 1.85
Childhood asthma and environmental exposures at swimming pools: state of the science and research recommendations. Environ Health Perspect (2008) 1.71
Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol Lett (2004) 1.70
The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation. Thorax (2011) 1.62
Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification. J Bone Miner Res (2013) 1.60
Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest (2005) 1.55
Nicotine activates the chemosensory cation channel TRPA1. Nat Neurosci (2009) 1.44
Adverse health effects of child labor: high exposure to chromium and oxidative DNA damage in children manufacturing surgical instruments. Environ Health Perspect (2012) 1.44
Progression of the prothrombotic state in aging Bmal1-deficient mice. Arterioscler Thromb Vasc Biol (2011) 1.43
Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice. J Bone Miner Res (2006) 1.39
Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase. J Bone Miner Res (2004) 1.36
Expert elicitation on ultrafine particles: likelihood of health effects and causal pathways. Part Fibre Toxicol (2009) 1.35
Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood (2005) 1.35
Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J (2004) 1.34
Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood (2002) 1.33
Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect (2008) 1.32
Pulmonary inflammation and thrombogenicity caused by diesel particles in hamsters: role of histamine. Am J Respir Crit Care Med (2003) 1.29
Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles. J Bone Miner Res (2010) 1.29
Pharmacological stabilization of mast cells abrogates late thrombotic events induced by diesel exhaust particles in hamsters. Circulation (2004) 1.25
Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood (2003) 1.21
Platelet JNK1 is involved in secretion and thrombus formation. Blood (2010) 1.20
Kinetic characterization of hypophosphatasia mutations with physiological substrates. J Bone Miner Res (2002) 1.19
Subclinical responses in healthy cyclists briefly exposed to traffic-related air pollution: an intervention study. Environ Health (2010) 1.15
Particulate matter in the environment: pulmonary and cardiovascular effects. Curr Opin Pulm Med (2007) 1.15
Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol Sci (2004) 1.14
Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography. PLoS One (2012) 1.14
Effects of particulate air pollution on hemostasis. Clin Occup Environ Med (2006) 1.14
Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. Int J Biochem Cell Biol (2005) 1.14
A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1. Blood (2012) 1.12
Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation. Hum Mol Genet (2003) 1.12
Involvement of the mitogen-activated protein kinase c-Jun NH2-terminal kinase 1 in thrombus formation. J Biol Chem (2007) 1.12
Concentration response functions for ultrafine particles and all-cause mortality and hospital admissions: results of a European expert panel elicitation. Environ Sci Technol (2010) 1.12
High human exposure to cobalt and other metals in Katanga, a mining area of the Democratic Republic of Congo. Environ Res (2009) 1.12
Air pollution related prothrombotic changes in persons with diabetes. Environ Health Perspect (2010) 1.11
Oropharyngeal aspiration: an alternative route for challenging in a mouse model of chemical-induced asthma. Toxicology (2009) 1.11
Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J Allergy Clin Immunol (2006) 1.09
A novel phosphatase upregulated in Akp3 knockout mice. Am J Physiol Gastrointest Liver Physiol (2007) 1.09
Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice. Circ Res (2008) 1.08
Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2002) 1.05
Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs. Cardiovasc Res (2002) 1.05
Media warnings about environmental pollution facilitate the acquisition of symptoms in response to chemical substances. Psychosom Med (2003) 1.04
Induction of IL-6 and inhibition of IL-8 secretion in the human airway cell line Calu-3 by urban particulate matter collected with a modified method of PM sampling. Environ Res (2009) 1.03
Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. Hum Mol Genet (2002) 1.03
Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood (2002) 1.03
Mouse models to unravel the role of inhaled pollutants on allergic sensitization and airway inflammation. Respir Res (2010) 1.03
Immunological determinants of ventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate. Am J Physiol Lung Cell Mol Physiol (2006) 1.01
Occupational cadmium exposure and calcium excretion, bone density, and osteoporosis in men. J Bone Miner Res (2010) 1.01
Where do the elderly die? The impact of nursing home utilisation on the place of death. Observations from a mortality cohort study in Flanders. BMC Public Health (2006) 1.01
Function assignment to conserved residues in mammalian alkaline phosphatases. J Biol Chem (2002) 1.00
Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts. Int Arch Allergy Immunol (2010) 1.00
The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation. J Clin Invest (2004) 0.99
Interactions of nanomaterials with the immune system. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 0.99
How physico-chemical characteristics of nanoparticles cause their toxicity: complex and unresolved interrelations. Environ Sci Process Impacts (2013) 0.97
Does air pollution trigger infant mortality in Western Europe? A case-crossover study. Environ Health Perspect (2011) 0.97
Proteoliposomes harboring alkaline phosphatase and nucleotide pyrophosphatase as matrix vesicle biomimetics. J Biol Chem (2010) 0.96
Blood pressure and particulate air pollution in schoolchildren of Lahore, Pakistan. BMC Public Health (2012) 0.96
Development of a physiologically based kinetic model for 99m-technetium-labelled carbon nanoparticles inhaled by humans. Inhal Toxicol (2009) 0.96
How long do the systemic and ventilatory responses to toluene diisocyanate persist in dermally sensitized mice? J Allergy Clin Immunol (2007) 0.95
Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation. Arterioscler Thromb Vasc Biol (2007) 0.95
Choice of mouse strain influences the outcome in a mouse model of chemical-induced asthma. PLoS One (2010) 0.95
Differential Involvement of ERK2 and p38 in platelet adhesion to collagen. J Biol Chem (2005) 0.95
Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets. Blood (2006) 0.95
Impact of clock gene Bmal1 deficiency on nutritionally induced obesity in mice. Obesity (Silver Spring) (2010) 0.95
Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation. Exp Cell Res (2006) 0.94
Silica particles enhance peripheral thrombosis: key role of lung macrophage-neutrophil cross-talk. Am J Respir Crit Care Med (2005) 0.93